Yahoo Web Search

Search results

    • Small Business - The Andalusia Star-News | The Andalusia Star-News

      The Andalusia Star-News· 5 days ago

      - Clinically meaningful and statistically significant improvements across multiple angioedema measurements and barzolvolimab dose groups -- Sustained activity with rapid onset within 2 weeks -- Data further support barzolvolimab clinical benefit

    • President hails signing of trilateral rail agreement

      China Daily· 9 hours ago

      President Xi Jinping offered congratulations on the signing of an intergovernmental agreement on the China-Kyrgyzstan-Uzbekistan railway project on Thursday, saying that China is committed to ...

    • Small Business - Shelby County Reporter | Shelby County Reporter

      The Shelby County Reporter· 4 hours ago

      NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody